Concepedia

David Sciberras

DS

Statistics

Publications

25

Citations

2K

H-Index

21

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

UCB Pharma (Belgium)

United States Military Academy

University of Edinburgh

David Sciberras is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

1991–2020

25

Publications

25

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

Cynthia Guzzo, Christine Furtek, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2002 · 366 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

Cynthia Guzzo, Christine Furtek, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2002 · 311 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

Sohail A. Khan, John А. Kanis, Samuel D Vasikaran et al. · Journal of Bone and Mineral Research · 1997 · 293 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +17

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

Mats Bergström, Richard Hargreaves, H. Donald Burns et al. · Biological Psychiatry · 2004 · 199 citations

Medicine, Neuroscience, Pharmacology +12

Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue

Michel Koole, June van Aalst, Martijn Devrome et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 143 citations · Full text

Medicine, Neuroscience, Nuclear Medicine +13

1–5 of 25